Anaplastic lymphoma kinase in human cancer

被引：93

作者：

Barreca, Antonella ^{[1
,2
]}

Lasorsa, Elena ^{[1
,2
]}

Riera, Ludovica ^{[1
,2
]}

Machiorlatti, Rodolfo ^{[1
,2
]}

Piva, Roberto ^{[1
,2
,3
]}

Ponzoni, Maurilio ^{[4
]}

Kwee, Ivo ^{[5
,6
]}

Bertoni, Francesco ^{[5
,6
]}

Piccaluga, Pier Paolo ^{[7
]}

Pileri, Stefano A. ^{[7
]}

Inghirami, Giorgio ^{[1
,2
,3
]}

机构：

[1] Univ Turin, Dept Pathol, I-10126 Turin, Italy

[2] Univ Turin, CeRMS, I-10126 Turin, Italy

[3] NYU, Sch Med, NYU Canc Ctr, Dept Pathol, New York, NY 10016 USA

[4] Ist Sci San Raffaele, Unit Lymphoid Malignancies, I-20132 Milan, Italy

[5] Oncol Inst So Switzerland IOSI, Expt Oncol Lab, CH-6900 Bellinzona, Switzerland

[6] Oncol Inst So Switzerland IOSI, Lymphoma Unit, CH-6900 Bellinzona, Switzerland

[7] Univ Bologna, S Orsola Malpighi Hosp, Dept Hematol & Oncol Sci L&A Seragnoli, Hematopathol Sect, I-40138 Bologna, Italy

来源：

JOURNAL OF MOLECULAR ENDOCRINOLOGY | 2011年 / 47卷 / 01期

关键词：

LARGE-CELL LYMPHOMA; RECEPTOR TYROSINE KINASE; EML4-ALK FUSION GENE; INFLAMMATORY MYOFIBROBLASTIC TUMOR; SMALL-MOLECULE INHIBITOR; NON-HODGKINS-LYMPHOMA; HEAVY-CHAIN GENE; ALK FUSION; NPM-ALK; GROWTH-FACTOR;

D O I：

10.1530/JME-11-0004

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The receptor tyrosine kinases (RTKs) play a critical role, controlling cell proliferation, survival, and differentiation of normal cells. Their pivotal function has been firmly established in the pathogenesis of many cancers as well. The anaplastic lymphoma kinase (ALK), a transmembrane RTK, originally identified in the nucleophosmin (NPM)-ALK chimera of anaplastic large cell lymphoma, has emerged as a novel tumorigenic player in several human cancers. In this review, we describe the expression of the ALK-RTK, its related fusion proteins, and their molecular mechanisms of activation. Novel tailored strategies are briefly illustrated for the treatment of ALK-positive neoplasms.

引用

页码：R11 / R23

页数：13

共 155 条

[21] The anaplastic lymphoma kinase in the pathogenesis of cancer [J].

Chiarle, Roberto ;

Voena, Claudia ;

Ambrogio, Chiara ;

Piva, Roberto ;

Inghirami, Giorgio .

NATURE REVIEWS CANCER, 2008, 8 (01) :11-23

[22] ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC) [J].

Chikatsu, N ;

Kojima, H ;

Suzukawa, K ;

Shinagawa, A ;

Nagasawa, T ;

Ozawa, H ;

Yamashita, Y ;

Mori, N .

MODERN PATHOLOGY, 2003, 16 (08) :828-832

[23] Cytomorphology and molecular characterization of CLTC-ALK rearrangement in 2 cases of ALK-positive diffuse large B-cell lymphoma with extensive bone marrow involvement [J].

Choung, Hee-Suk ;

Kim, Hee-Jin ;

Kim, Won-Seog ;

Kim, Kihyun ;

Kim, Sun-Hee .

KOREAN JOURNAL OF LABORATORY MEDICINE, 2008, 28 (02) :89-94

[24] Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma [J].

Christensen, James G. ;

Zou, Helen Y. ;

Arango, Maria E. ;

Li, Qiuhua ;

Lee, Joseph H. ;

McDonnell, Scott R. ;

Yamazaki, Shinji ;

Alton, Gordon R. ;

Mroczkowski, Barbara ;

Los, Gerrit .

MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) :3314-3322

[25] ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor [J].

Coffin, CM ;

Patel, A ;

Perkins, S ;

Elenitoba-Johnson, KSJ ;

Perlman, E ;

Griffin, CA .

MODERN PATHOLOGY, 2001, 14 (06) :569-576

[26] ATIC-ALK:: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35) [J].

Colleoni, GWB ;

Bridge, JA ;

Garicochea, B ;

Liu, J ;

Filippa, DA ;

Ladanyi, M .

AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (03) :781-789

[27] Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor - A comparative immunohistochemical study [J].

Cook, JR ;

Dehner, LP ;

Collins, MH ;

Ma, ZG ;

Morris, SW ;

Coffin, CM ;

Hill, DA .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (11) :1364-1371

[28] Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor [J].

Cools, J ;

Wlodarska, I ;

Somers, R ;

Mentens, N ;

Pedeutour, F ;

Maes, B ;

De Wolf-Peeters, C ;

Pauwels, P ;

Hagemeijer, A ;

Marynen, P .

GENES CHROMOSOMES & CANCER, 2002, 34 (04) :354-362

[29] ALK Expression in Rhabdomyosarcomas: Correlation with Histologic Subtype and Fusion Status [J].

Corao, Diana A. ;

Biegel, Jaclyn A. ;

Coffin, Cheryl M. ;

Barr, Frederic G. ;

Wainwright, Luanne M. ;

Ernst, Linda M. ;

Choi, John K. ;

Zhang, Paul J. ;

Pawel, Bruce R. .

PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2009, 12 (04) :275-283

[30] ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma [J].

De Paepe, P ;

Baens, M ;

van Krieken, H ;

Verhasselt, B ;

Stul, M ;

Simons, A ;

Poppe, B ;

Laureys, G ;

Brons, P ;

Vandenberghe, P ;

Speleman, F ;

Praet, M ;

De Wolf-Peeters, C ;

Marynen, P ;

Wlodarska, I .

BLOOD, 2003, 102 (07) :2638-2641

← 1 2 3 4 5 6 7 8 9 10 →